384 results on '"Mahler, Donald A."'
Search Results
2. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD
3. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review
4. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
5. Effect of ensifentrine on dyspnea in patients with moderate-to-severe chronic obstructive pulmonary disease: pooled analysis of the ENHANCE trials.
6. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers
7. The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease
8. Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.
9. Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3)
10. Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease.
11. Indacaterol vs tiotropium in COPD patients classified as GOLD A and B
12. Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity
13. Inflammation in COPD: Implications for Management
14. Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD
15. Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy
16. American College of Chest Physicians Consensus Statement on the Management of Dyspnea in Patients With Advanced Lung or Heart Disease
17. Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease
18. FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease
19. Prospective Use of Descriptors of Dyspnea to Diagnose Common Respiratory Diseases
20. A Perspective on Web-based Information for Patients with Chronic Lung Disease
21. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
22. Recent Advances in Dyspnea
23. Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD
24. Perceptual and Physiologic Responses During Treadmill and Cycle Exercise in Patients With COPD
25. Response
26. One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD
27. REMOTELY RECORDED PEAK INHALATION FLOW PATTERNS AMONG PATIENTS WITH COPD USING PROAIR DIGIHALER FOR RESCUE MEDICATION
28. Use of Inhaled Corticosteroids in Patients With COPD and the Risk of TB and Influenza: A Systematic Review and Meta-analysis of Randomized Controlled Trials
29. Minimal Clinically Important Differences in Pharmacological Trials
30. A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in Chronic Obstructive Pulmonary Disease.
31. Effect of Increased Blood Levels of β-Endorphin on Perception of Breathlessness
32. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
33. Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD.
34. 221E. Indacaterol 75 μg once daily improves health status in patients with moderate-to-severe COPD: responder analysis.
35. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison
36. An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea
37. Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol Versus Tiotropium
38. Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.
39. Dexamethasone for cancer-related dyspnoea – Authors' reply
40. Are You Fluent in the Language of Dyspnea?
41. Validity and Responsiveness of the Self-Administered Computerized Versions of the Baseline and Transition Dyspnea Indexes*
42. Assessment Tools for Chronic Obstructive Pulmonary Disease: Do Newer Metrics Allow For Disease Modification?
43. Pulmonary Rehabilitation*: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
44. Pulmonary Rehabilitation Executive Summary*: Joint American College of Chest Physicians/American Association of Cardiovascular and Pulmonary Rehabilitation Evidence-Based Clinical Practice Guidelines
45. The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
46. Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable
47. Is physical activity anti-inflammatory on the airways?
48. Responsiveness of Patient-Reported Breathlessness During Exercise in Persistent Asthma*
49. Continuous Ratings of Breathlessness During Exercise by Children and Young Adults With Asthma and Healthy Controls
50. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.